Marzilli Luigi G., Intini Francesco P., Kiser Danita, Wong Hing C., Ano Susan O., Marzilli Patricia A., Natile Giovanni
Department of Chemistry, Emory University, Atlanta, Georgia 30322, and Dipartimento Farmaco-Chimico, Università degli Studi di Bari, 70125 Bari, Italy.
Inorg Chem. 1998 Dec 28;37(26):6898-6905. doi: 10.1021/ic980843f.
Chirality-controlling chelate (CCC) ligands are a class of chiral diamine ligands with one or two chiral secondary amine ligating groups. Analogues of platinum anticancer agents containing CCC ligands exhibit unusual steric and dynamic features. In this study NMR and CD methods were used to evaluate the influence of the N9 substituent in guanine derivatives (G) on conformer distribution in one class of (CCC)PtG(2)() complexes. We employed the CCC ligand, N,N'-dimethyl-2,3-diaminobutane [Me(2)()DAB with S,R,R,S or R,S,S,R configurations at the four asymmetric centers, N, C, C, and N]. For each Me(2)()DABPtG(2) complex, the presence of four G H8 signals demonstrated formation of all three possible atropisomers: DeltaHT (head-to-tail), LambdaHT, and HH (head-to-head). Different G ligands (5'-GMP, 3'-GMP, 1-MeGuo, Guo, or 9-EtG) were chosen to assess the effect of the N9 substituent on the relative stability and spectral properties of the atropisomers. The conformations of the atropisomers of Me(2)()DABPtG(2) were determined from CD spectra and from NOE cross-peaks (assigned via COSY spectra) between G H8 signals and those for the Me(2)()DAB protons. Regardless of the N9 substituent, the major form was HT. However, this form had the opposite chirality, LambdaHT and DeltaHT, and base tilt direction, left- and right-handed, respectively, for the S,R,R,S and R,S,S,R configurations of the Me(2)()DAB ligand. Thus, the chirality of the CCCligand, not hydrogen bonding, is the most important determinant of conformation. For each Me(2)()DABPtG(2) complex, the tilt direction of all three atropisomers is the same and, except for 5'-GMP, the order of abundance was major HT > minor HT > HH. For 5'-GMP, the HH atropisomer was three times as abundant as the minor HT species, suggesting that phosphate-NH(Me(2)()DAB) hydrogen bonds could be present since such bonding is possible only for the 5'-GMP derivatives. However, if such phosphate-NH hydrogen bonds exist, they are weak since the percentage of the major HT form of 5'-GMP complexes is similar and indeed can be smaller compared to this percentage for complexes with other G's. The CD spectra of all (S,R,R,S)-Me(2)()DABPtG(2) complexes were similar and opposite to those of all (R,S,S,R)-Me(2)()DABPtG(2) complexes, indicating the CD signature is characteristic of the dominant HT conformer, which has a chirality dictated by the chirality of the CCC ligand and not the N9 substituent.
手性控制螯合(CCC)配体是一类具有一个或两个手性仲胺连接基团的手性二胺配体。含有CCC配体的铂类抗癌剂类似物表现出不同寻常的空间和动态特征。在本研究中,采用核磁共振(NMR)和圆二色(CD)方法评估鸟嘌呤衍生物(G)中N9取代基对一类(CCC)PtG(2)配合物构象分布的影响。我们使用了CCC配体N,N'-二甲基-2,3-二氨基丁烷[在四个不对称中心N、C、C和N处具有S,R,R,S或R,S,S,R构型的Me(2)DAB]。对于每个Me(2)DABPtG(2)配合物,四个G H8信号的存在表明形成了所有三种可能的阻转异构体:ΔHT(头对头)、ΛHT和HH(头对尾)。选择不同的G配体(5'-鸟苷酸、3'-鸟苷酸、1-甲基鸟嘌呤、鸟嘌呤或9-乙基鸟嘌呤)来评估N9取代基对阻转异构体相对稳定性和光谱性质的影响。Me(2)DABPtG(2)阻转异构体的构象由CD光谱以及G H8信号与Me(2)DAB质子信号之间的核Overhauser效应(NOE)交叉峰(通过COSY光谱确定)确定。无论N9取代基如何,主要形式都是HT。然而,对于Me(2)DAB配体的S,R,R,S和R,S,S,R构型,这种形式具有相反的手性,分别为ΛHT和ΔHT,并且碱基倾斜方向分别为左旋和右旋。因此,CCC配体的手性而非氢键是构象的最重要决定因素。对于每个Me(2)DABPtG(2)配合物,所有三种阻转异构体的倾斜方向相同,除了5'-鸟苷酸外,丰度顺序为主要HT>次要HT>HH。对于5'-鸟苷酸,HH阻转异构体的丰度是次要HT物种的三倍,这表明可能存在磷酸根-NH(Me(2)DAB)氢键,因为这种键合仅对5'-鸟苷酸衍生物是可能的。然而,如果存在这种磷酸根-NH氢键,它们是弱的,因为5'-鸟苷酸配合物主要HT形式的百分比与其他G配合物的该百分比相似,甚至可能更小。所有(S,R,R,S)-Me(2)DABPtG(2)配合物的CD光谱相似且与所有(R,S,S,R)-Me(2)DABPtG(2)配合物的CD光谱相反,这表明CD特征是占主导地位的HT构象的特征,其手性由CCC配体的手性而非N9取代基决定。